Generic drug competition: The pharmaceutical industry “gaming” controversy

Business and Society Review 124 (4):467-477 (2019)
  Copy   BIBTEX

Abstract

Among American adults 20 years and older, 59 percent take at least one prescription drug on a regular basis. Unlike most branded drugs, which are generally drugs that have a trade name and are protected by a patent, off‐patent generic drugs make up approximately 90 percent of prescriptions annually filled in the United States; yet in 2017, generic drugs made up only 23 percent of total drug costs in the U.S. The U.S. Food and Drug Administration has taken the lead in encouraging increased competition in the nation's prescription drug marketplace, most recently with its release of the agency's Drug Competition Action Plan, but also with its regulatory guidance and enforcement efforts to eliminate “gaming” of the regulatory process by both branded and generic pharmaceutical manufacturers. Such “gaming” activities include “pay‐for‐delay” agreements involving financial compensation between branded and generic pharmaceutical manufacturers to forestall the emergence into the market of generic pharmaceuticals to compete against a formerly patent‐protected branded drug. A combination of new enabling legislation, federal judicial guidance, and agency regulatory activities show promise in encouraging increased competition in the prescription drug marketplace, with the American consumer the ultimate beneficiary of lower health care costs and improved overall personal health.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 98,109

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Drugs, Money, and Power: The Canadian Drug Shortage.Chris Kaposy - 2014 - Journal of Bioethical Inquiry 11 (1):85-89.
The use of generic or patent medicines in the Netherlands.D. O. E. Gebhardt - 2005 - Journal of Medical Ethics 31 (7):409-409.

Analytics

Added to PP
2019-11-26

Downloads
19 (#944,262)

6 months
9 (#383,898)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references